Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Dinoprostone and Manganese

supplement:

Manganese

Research Papers that Mention the Interaction

Additionally, Mn increased interleukin1-β and prostaglandin E2 levels and altered caspase-3 and Bcl-2 expression.
Biological Trace Element Research  •  2018  |  View Paper
Moreover, the authors report a doseand ime-dependent increase in brain prostaglandin E2 levels (used as biomarker of neuroinflammation) due to Mn , that is statistically ignificant only in the 8 dose Mn treated group vs. the control group Santos et al., 2012).
Toxicology  •  2012  |  View Paper
Mn injections (days 1, 4 and 7) induced significant increases in F2-IsoPs and PGE2 in adult mouse brain 24 h following the last injection.
Treatment of neurons with 500 microM Mn also resulted in time-dependent increases in the levels of the inflammatory biomarker, prostaglandin E2 (PGE2).
Toxicology and applied pharmacology  •  2009  |  View Paper
Manganese potentiated COX-2 expression and PGE2 generation by lipopolysaccharide/interferon-gamma-activated astrocytes.
Within non-toxic concentrations, manganese caused an elevation in the expression of cyclooxygenase-2 (COX-2) mRNA and protein and increased PGE2 release.
Neurochemistry International  •  2007  |  View Paper
Manganese as inhibitor of the A23187-induced calcium influx decreased PGE2 synthesis.
Biochemical pharmacology  •  1990  |  View Paper
Ca2+-channel antagonists, such as nifedipine, verapamil, diltiazem and manganese inhibited PAF-induced arachidonate and PGE2 release in a dose-dependent manner.
The Biochemical journal  •  1985  |  View Paper